Cited by 603Diabetes Management and ResearchDiabetes Treatment and ManagementPeripheral Neuropathies and Disorders

The DOI matches its Crossref record.

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

The Diabetes Control and Complications Trial Research Group.·1995·Annals of Internal Medicine

DOI 10.7326/0003-4819-122-8-199504150-00001

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To examine whether intensive therapy designed to achieve glycemic levels as close to normal as possible prevents or slows the progression of neuropathy when compared with conventional therapy in patients with insulin-dependent diabetes mellitus in the Diabetes Control and Complications Trial. DESIGN: Multicenter, randomized, controlled clinical trial. SETTING: 29 U.S. and Canadian clinical centers. PARTICIPANTS: 1441 patients aged 13 to 39 years, of whom 726 had had insulin-dependent diabetes mellitus for 1 to 5 years and had no retinopathy at baseline (primary prevention cohort); 715 had had diabetes for 1 to 15 years and had minimal to moderate nonproliferative retinopathy at baseline (secondary intervention cohort). INTERVENTION: Intensive therapy with three or more daily insulin injections or continuous subcutaneous insulin infusion guided by four or more glucose tests per day compared with conventional therapy with one or two daily insulin injections. RESULTS: Intensive therapy reduced the development of confirmed clinical neuropathy (defined as a history or physical examination consistent with clinical neuropathy confirmed by either abnormal nerve conduction or autonomic nervous system testing) by 64% (95% CI, 45% to 76%) in the combined cohorts after 5 years of follow-up (5% of the intensive therapy group compared with 13% of the conventional therapy group). The prevalence of abnormal nerve conduction and abnormal autonomic nervous system function were reduced by 44% (CI, 34% to 53%) and 53% (CI, 24% to 70%), respectively (26% of the intensive treatment group developed abnormal nerve conduction compared with 46% of the conventional treatment group; 4% of the intensive treatment group had abnormal autonomic nervous system function compared with 9% of the conventional treatment group). Finally, nerve conduction velocities generally remained stable with intensive therapy but decreased significantly with conventional therapy. CONCLUSION: Intensive diabetes therapy markedly delays or prevents the development of clinically manifest diabetic polyneuropathy as confirmed by objective nerve function testing in patients with insulin-dependent diabetes mellitus.

Integrity signals

Registry

Crossref · 10.7326/0003-4819-122-8-199504150-00001

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 101–200 of 603

Dissection of Metabolic, Vascular, and Nerve Conduction Interrelationships in Experimental Diabetic Neuropathy by Cyclooxygenase Inhibition and Acetyl- l -Carnitine Administration
Pop‐Busui, R., Marinescu, V., Huysen, C. V., Li, F. Y., Sullivan, K., Greene, D. A., Larkin, D. D., & Stevens, M. J. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2619 · Cited by 108
Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats
Yu, J., Zhang, Y., Sun, S., et al. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-015 · Cited by 107
The Diabetic Neuropathies
Gooch, C. L., & Podwall, D. (2004) · The Neurologist · doi:10.1097/01.nrl.0000144733.61110.25 · Cited by 107
Treatment of Diabetic Sensory Polyneuropathy
Zilliox, L. A., & Russell, J. W. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0113-1 · Cited by 105
Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia
Halawa, M. R., Karawagh, A. M., Zeidan, A. Z., Mahmoud, A.-E.-D. H., Sakr, M., Hegazy, A., & on behalf of the painful diabetic peripheral neuropathy study group (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903471940 · Cited by 101
A Role for Insulin in Diabetic Neuropathy
Grote, C. W., & Wright, D. E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00581 · Cited by 105
“Furthermore, patients on conventional therapy experienced a steady deterioration in nerve conduction velocity, while patients in the intensive treatment group displayed no change and even a slight improvement (Diabetes Control Complications Trial Research Group, 1995a; Diabetes Control Complications Trial (DCCT) Resea…”
BackgroundMethod
Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions
Javed, S., Alam, U., & Malik, R. A. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.63 · Cited by 92
Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain
Kuhad, A., Sharma, S., & Chopra, K. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2007.10.008 · Cited by 92
Clinical Manifestations and Current Treatment options for Diabetic Neuropathies
CASELLINI, C. M., & Vinik, A. I. (2007) · Endocrine Practice · doi:10.4158/ep.13.5.550 · Cited by 95
Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes
Weintrob, N., Amitay‐Laish, I., Lilos, P., Shalitin, S., Lazar, L., & JOSEFSBERG, Z. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.11.002 · Cited by 92
Depletion of Taurine in Experimental Diabetic Neuropathy: Implications for Nerve Metabolic, Vascular, and Functional Deficits
Pop‐Busui, R., Sullivan, K. A., Huysen, C. V., et al. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7591 · Cited by 90
The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes
Voulgari, C., Psallas, M., Kokkinos, A. D., Argiana, V., Katsilambros, N. L., & Tentolouris, N. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.06.001 · Cited by 91
Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: An assessment by C-11 hydroxyephedrine and positron emission tomography
Stevens, M. J., Raffel, D. M., Allman, K. C., Schwaiger, M., & Wieland, D. M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90016-1 · Cited by 85
Review Paper: Basic Concepts to Novel Therapies: A Review of the Diabetic Foot
O’Loughlin, A., McIntosh, C. D., Dinneen, S. F., & O’Brien, T. (2010) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734610371600 · Cited by 85
Painful diabetic neuropathy: Diagnosis and management
Hartemann, A., Attal, N., Bouhassira, D., Dumont, I., Gin, H., Jeanne, S., Saïd, G., & Richard, J.-L. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.06.003 · Cited by 87
Prevalence and Correlates of Diabetic Peripheral Neuropathy in a Saudi Arabic Population: A Cross-Sectional Study
Wang, D. D., Bakhotmah, B. A., Hu, F. B., & Alzahrani, H. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106935 · Cited by 82
Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy
Stavniichuk, R., Shevalye, H., Lupachyk, S., Obrosov, A. A., Groves, J. T., Obrosova, I. G., & Yorek, M. A. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2549 · Cited by 79
“Improved blood glucose control reduces the risk of diabetic neuropathy, thus implicating hyperglycaemia as a leading causative factor [1].”
Background
The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes
Paterson, A. D., Rutledge, B. N., Cleary, P. A., Lachin, J. M., Crow, R. S., & for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2007) · Diabetes Care · doi:10.2337/dc06-1441 · Cited by 81
A comparison of electrophysiological tests for the early diagnosis of diabetic neuropathy
Pastore, C. A., Izura, V., Geijo‐Barrientos, E., & Dominguez, J.-R. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199912)22:12 · Cited by 79
Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes
Martin, C. L., Waberski, B. H., Pop‐Busui, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0616 · Cited by 81
Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy
Burger, A. J., Weinrauch, L. A., D’Elia, J. A., et al. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00417-8 · Cited by 81
Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes
Stella, P., Ellis, D., Maser, R. E., & Orchard, T. J. (2000) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00054-4 · Cited by 80
Higher Levels of Inflammation Factors and Greater Insulin Resistance Are Independently Associated with Higher Heart Rate and Lower Heart Rate Variability in Normoglycemic Older Individuals: The Cardiovascular Health Study
Stein, P. K., Barzilay, J. I., Chaves, P. H. M., Traber, J. N., Domitrovich, P. P., Heckbert, S. R., & Gottdiener, J. S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01564.x · Cited by 80
Natural Progression of Diabetic Peripheral Neuropathy in the Zenarestat Study Population
Brown, M. J., Bird, S. J., Watling, S., Kaleta, H., Hayes, L., Eckert, S., & Foyt, H. L. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1153 · Cited by 78
Elucidation of ameliorative effect of Co-enzyme Q10 in streptozotocin-induced diabetic neuropathic perturbation by modulation of electrophysiological, biochemical and behavioral markers
Visnagri, A., Kandhare, A. D., Kumar, V. S., Rajmane, A. R., Mohammad, A., Ghosh, P., Ghule, A. E., & Bodhankar, S. L. (2012) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2012.10.006 · Cited by 78
Redistribution of Sudomotor Responses Is an Early Sign of Sympathetic Dysfunction in Type 1 Diabetes
Hoeldtke, R. D., Bryner, K. D., Horvath, G. G., Phares, R. W., Broy, L. F., & Hobbs, G. R. (2001) · Diabetes · doi:10.2337/diabetes.50.2.436 · Cited by 77
Forced‐exercise delays neuropathic pain in experimental diabetes: effects on voltage‐activated calcium channels
Shankarappa, S. A., Piedras-Renterı́a, E. S., & Stubbs, E. B. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07302.x · Cited by 78
Clinical Potential of Insulin Therapy in Critically Ill Patients
Mesotten, D., & den Berghe, G. V. (2003) · Drugs · doi:10.2165/00003495-200363070-00001 · Cited by 74
Development and validation of risk assessment models for diabetes-related complications based on the DCCT/EDIC data
Lagani, V., Chiarugi, F., Thomson, S., Fursse, J., Lakasing, E., Jones, R. W., & Tsamardinos, I. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.03.001 · Cited by 74
Painful diabetic neuropathy: an update.
Kaur, S., Pandhi, P., & Dutta, P. R. (2011) · PubMed · doi:10.5214/ans.0972-7531.1118409 · Cited by 73
Recurrent Hypoglycemia Exacerbates Cerebral Ischemic Damage in Streptozotocin-Induced Diabetic Rats
Dave, K. R., Tamariz, J., Desai, K., Brand, F. J., Liu, A., Saul, I., Bhattacharya, S. K., & Pileggi, A. (2011) · Stroke · doi:10.1161/strokeaha.110.594937 · Cited by 73
NEUROLOGIC ERECTILE DYSFUNCTION
Nehra, A. X., & Moreland, R. B. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70139-7 · Cited by 74
Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy
Rutkove, S. B., & McIlduff (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s11325 · Cited by 71
Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7‐year follow‐up study
Ko, S., Song, K., Park, S. A., Kim, S. R., Y., B., Son, H., Moon, K., Yoo, K., Park, Y., Cho, J. H., et al. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02567.x · Cited by 68
A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy
Cai, Z., Yang, Y., & Zhang, J. (2021) · Scientific Reports · doi:10.1038/s41598-020-79276-0 · Cited by 75
The Eurodiab study: What has this taught us about diabetic peripheral neuropathy?
Tesfaye, S. H., & Selvarajah, D. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0070-1 · Cited by 67
Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy
Didangelos, T., Karlafti, E., Kotzakioulafi, E., Kontoninas, Z., Margaritidis, C., Giannoulaki, P., & Kantartzis, K. (2020) · Nutrients · doi:10.3390/nu12113254 · Cited by 70
“Due to the painful symptoms and resulting disabilities, DN strongly affects quality of life [4,9,10].”
BackgroundMethod
Épidémiologie du pied diabétique
Richard, J.-L., & Schuldiner, S. (2008) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(08)73949-3 · Cited by 78
Neuropathy
Bril, V., Breiner, A., Perkins, B. A., & Zochodne, D. W. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.028 · Cited by 80
The role of protein kinase C in the development of the complications of diabetes
Ways, D. K., & Sheetz, M. J. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)60019-5 · Cited by 65
Effect of oat intake on glycaemic control and insulin sensitivity: a meta-analysis of randomised controlled trials
Bao, L., Cai, X., Xu, M., & Li, Y. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000889 · Cited by 65
Evidence of defective cardiovascular regulation in insulin-dependent diabetic patients without clinical autonomic dysfunction
Weston, P. J., James, M. A., Panerai, R. B., McNally, P. G., Potter, J. F., & Thurston, H. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00094-1 · Cited by 63
Exercise as Therapy for Diabetic and Prediabetic Neuropathy
Singleton, J. R., Smith, A. G., & Marcus, R. L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0682-6 · Cited by 71
In Vivo Corneal Confocal Microscopy and Prediction of Future-Incident Neuropathy in Type 1 Diabetes: A Preliminary Longitudinal Analysis
Lovblom, L. E., Halpern, E. M., Wu, T., Kelly, D., Ahmed, A., Boulet, G., Orszag, A., Ng, E., Ngo, M., Bril, V., et al. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.02.006 · Cited by 64
Peripheral Diabetic Neuropathy
Fedele, D., & Giugliano, D. (1997) · Drugs · doi:10.2165/00003495-199754030-00004 · Cited by 64
Update on the management of diabetic polyneuropathies
Stevens, M. J., & Shakher, J. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s11324 · Cited by 82
“These studies were, however, limited to a small number of patients.(72,73)”
Neuropathic pain: Etiology, pathophysiology, mechanisms, and evaluations
Jay, G. W., & Barkin, R. L. (2014) · Disease-a-Month · doi:10.1016/j.disamonth.2013.12.001 · Cited by 63
Evaluation of balance and physical fitness in diabetic neuropathic patients
Cımbız, A., & Cakir, O. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.06.005 · Cited by 62
Assessment of baroreceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM and the relation to left ventricular mass index
Panerai, R. B., McCullough, A. J., Weston, P. J., McNally, P. G., Potter, J. F., Swales, J. D., James, M. A., & Thurston, H. (1996) · Diabetologia · doi:10.1007/s001250050587 · Cited by 62
C‐peptide: new findings and therapeutic implications in diabetes
Wahren, J. (2004) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2004.00558.x · Cited by 60
Heart rate variability and circadian variations in type 1 diabetes mellitus
Kardelen, F., Akçurin, G., Ertuğ, H., Akçurin, S., & Bircan, İ. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2006.00141.x · Cited by 62
The Epidemiology of Diabetic Neuropathy
Boyko, E. J. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_1 · Cited by 61
Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study
Παπάνας, Ν., Giassakis, G., Papatheodorou, K., Papazoglou, D., Monastiriotis, C., Christakidis, D., Piperidou, H., & Maltezos, E. S. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.08.003 · Cited by 57
Impaired glucose tolerance—does it cause neuropathy?
Russell, J. W., & Feldman, E. L. (2001) · Muscle & Nerve · doi:10.1002/mus.1122 · Cited by 59
Advanced Diabetic Neuropathy: A Point of no Return?
Bouček, P. (2006) · The Review of Diabetic Studies · doi:10.1900/rds.2006.3.143 · Cited by 58
“Optimal metabolic control is the only available measure with proven efficacy in preventing or at least halting the progression of diabetic neuropathy [3].”
Background
Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: Relationship to microvascular complications and bone mineral density
AboElAsrar, M. A., Elbarbary, N. S., ElShennawy, D. E.-S., & Omar, A. M. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.019 · Cited by 57
Painful diabetic neuropathy
Didangelos, T., Doupis, J., & Veves, A. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00005-9 · Cited by 62
Diabetic Neuropathy
Smith, A. G., & Singleton, J. R. (2012) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000411568.34085.3e · Cited by 90
The Diabetes Control and Complications Trial: the gift that keeps giving
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.179 · Cited by 59
The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects
Kästenbauer, T., Irsigler, P., Sauseng, S., Grimm, A., & Prager, R. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00071-0 · Cited by 58
Pharmacological Treatment of Diabetic Neuropathic Pain
Smith, H. S., & Argoff, C. E. (2011) · Drugs · doi:10.2165/11588940-000000000-00000 · Cited by 56
Evaluation of Patients With Symptoms Suggestive of Chronic Polyneuropathy
Johannsen, L., Smith, T., Havsager, A., et al. (2001) · Journal of Clinical Neuromuscular Disease · doi:10.1097/00131402-200112000-00001 · Cited by 56
Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: Diagnosis, pathogenesis, and associated genetic markers
Kallinikou, D., Soldatou, A., Tsentidis, C., Louraki, M., Kanaka‐Gantenbein, C., Kanavakis, E., & Karavanaki, K. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3178 · Cited by 58
Mini review: Lipids in Peripheral Nerve Disorders
Hornemann, T. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135455 · Cited by 66
Development and Validation of the Economic Assessment of Glycemic Control and Long-Term Effects of Diabetes (EAGLE) Model
Mueller, E., Maxion‐Bergemann, S., Gultyaev, D., Walzer, S., Freemantle, N., Mathieu, C., Bolinder, B., Gerber, R. A., Kvasz, M., & Bergemann, R. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.219 · Cited by 55
AUTOIMMUNE DIABETIC NEUROPATHY
Krendel, D. A., Zacharias, A., & Younger, D. S. (1997) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70358-3 · Cited by 55
Wherefore Art Thou, O Treatment for Diabetic Neuropathy?
Malik, R. A. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.03.008 · Cited by 54
Corneal nerve fiber pathology in Japanese type 1 diabetic patients and its correlation with antecedent glycemic control and blood pressure
Ishibashi, F., Okino, M., Ishibashi, M., Kawasaki, A., Endo, N., Kosaka, A., & Uetake, H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00157.x · Cited by 52
Different Roles of 12/15-Lipoxygenase in Diabetic Large and Small Fiber Peripheral and Autonomic Neuropathies
Obrosova, I. G., Stavniichuk, R., Drel, V. R., Shevalye, H., Vareniuk, І., Nadler, J. L., & Schmidt, R. E. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100178 · Cited by 54
Low Peripheral Nerve Conduction Velocities and Amplitudes Are Strongly Related to Diabetic Microvascular Complications in Type 1 Diabetes
Charles, M., Soedamah‐Muthu, S. S., Tesfaye, S. H., Fuller, J., Arezzo, J. C., Chaturvedi, N., Witte, D. R., & EURODIAB Prospective Complications Study Investigators (2010) · Diabetes Care · doi:10.2337/dc10-0456 · Cited by 53
Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes
Heller, S. R., Lawton, J., Amiel, S. A., Cooke, D. D., Mansell, P., Brennan, A., Elliott, D., Boote, J. D., Emery, C., Baird, W. O., et al. (2014) · Programme Grants for Applied Research · doi:10.3310/pgfar02050 · Cited by 55
Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy
Cox, A., Sagot, Y., Hédou, G., Grek, C. L., Wilkes, T., Vinik, A. I., & Ghatnekar, G. S. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00089 · Cited by 53
A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy
Ibrahim, S., Harris, N. D., Radatz, M. W. R., Selmi, F., Rajbhandari, S. M., Brady, L., Jakubowski, J. J., & Ward, J. D. (1999) · Diabetologia · doi:10.1007/s001250051222 · Cited by 53
Emerging drugs for diabetic neuropathy
Tahrani, A. A., Askwith, T., & Stevens, M. J. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.512610 · Cited by 52
Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan
Yoshida, Y., Kashiwabara, K., Hirakawa, Y., Tanaka, T., Noso, S., Ikegami, H., Ohsugi, M., Ueki, K., Mita, T., Watada, H., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000902 · Cited by 51
Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?
Malik, R. A. (2000) · Annals of Medicine · doi:10.3109/07853890008995903 · Cited by 51
Mechanistic approach towards diabetic neuropathy screening techniques and future challenges: A review
Pathak, R., Sachan, N., & Chandra, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113025 · Cited by 53
Early Electrophysiological Abnormalities and Clinical Neuropathy
Hyllienmark, L., Alstrand, N., Jönsson, B., Ludvigsson, J., Cooray, G., & Wahlberg-Topp, J. (2013) · Diabetes Care · doi:10.2337/dc12-2226 · Cited by 52
Diabetic Neuropathies
Llewelyn, J., Tomlinson, D. R., & Thomas, P. K. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50088-0 · Cited by 67
Duloxetine in the management of diabetic peripheral neuropathic pain
Boomershine, C. S., Ormseth, M. J., & Scholz, B. A. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s16358 · Cited by 49
Changing Perspectives in Diabetic Foot Ulcer Management
Dang, C. N., & Boulton, A. J. M. (2003) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734603002001002 · Cited by 46
Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy—a nationwide 5-year-study in Japan
Murase, Y., Imagawa, A., Hanafusa, T., Iwahashi, H., Uchigata, Y., Kanatsuka, A., Kawasaki, E., Kobayashi, T., Shimada, A., Shimizu, I., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0575-y · Cited by 49
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects
Katz, L., Gambale, J. J., Rothenberg, P., Vanapalli, S. R., Vaccaro, N. M., Xi, L., Polidori, D., Vets, E., Sarich, T. C., & Stein, P. P. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.169 · Cited by 47
Glycemic control is related to the severity of impaired thermal sensations in type 2 diabetes
Chao, C., Hsieh, S., Yang, W., Lin, Y., Lin, W., Tai, T., & Hsieh, S. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.734 · Cited by 48
Glucose-Induced Metabolic Memory in Schwann Cells: Prevention by PPAR Agonists
Kim, E., Isoda, F., Kurland, I. J., & Mobbs, C. V. (2013) · Endocrinology · doi:10.1210/en.2013-1097 · Cited by 49
Methods for assessing diabetic polyneuropathy: validity and reproducibility of the measurement of sensory symptom severity and nerve function tests
Valk, G. D., Grootenhuis, P. A., van Eijk, J. T. M., Bouter, L. M., & Bertelsmann, F. W. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00111-4 · Cited by 47
Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients
Cardoso, C. R. L., & Salles, G. F. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.02.004 · Cited by 49
Herpetic Eye Disease in Diabetic Patients
Kaiserman, I., Kaiserman, N., Nakar, S., et al. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.07.014 · Cited by 47
The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds
Coppini, D. V., Wellmer, A., Weng, C., Young, P. J., Anand, P., & Sönksen, P. H. (2001) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.0893 · Cited by 47
Impact of neurologic signs and symptoms on functional status in peripheral neuropathies
Molenaar, D. S. M., Vermeulen, M. J., de Visser, M., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.151 · Cited by 47
Therapeutic Strategies for Diabetic Neuropathy
Habib, A. A., & Brannagan, T. H. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0093-7 · Cited by 46
Effects of physical activity on the development and progression of microvascular complications in type 1 diabetes: retrospective analysis of the DCCT study
Makura-Kankwende, C. B. T., Nirantharakumar, K., Girling, A. J., Saravanan, P., & Narendran, P. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-37 · Cited by 48
Diabetic neuropathy
Charnogursky, G. A., Lee, H. X., & Lopez, N. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4087-0.00051-6 · Cited by 50
Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
Kaku, M. C., Vinik, A. I., & Simpson, D. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0609-2 · Cited by 48
Intramuscular Injection of Islet Neogenesis-Associated Protein Peptide Stimulates Pancreatic Islet Neogenesis in Healthy Dogs
Pittenger, G. L., Taylor, D., Johns, R. H., Burcus, N. I., Kosuri, S., & Vinik, A. I. (2006) · Pancreas · doi:10.1097/01.mpa.0000240609.56806.43 · Cited by 46
Hypoglycemia: A Complication of Diabetes Therapy in Children
Ryan, C. M., Gurtünca, N., & Becker, D. J. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.08.002 · Cited by 46
Progression of Cardiovascular Autonomic Dysfunction in Patients With Type 2 Diabetes
Ko, S., Park, S.-A., Cho, J., Song, K., Yoon, K., Cha, B., Son, H., Yoo, K., Moon, K., Park, Y., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0682 · Cited by 46
Disorders of Peripheral Nerves
Harati, Y., & Bosch, E. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7525-3.50118-7 · Cited by 46
Cardiovascular autonomic neuropathy: Diagnosis and management
Vinik, A. I., & Erbas, T. A. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0074-z · Cited by 44
4.5-GRAM MONOFILAMENT SENSATION BENEATH BOTH FIRST METATARSAL HEADS INDICATES PROTECTIVE FOOT SENSATION IN DIABETIC PATIENTS
Saltzman, C. L., Rashid, R. H., HAYES, A., Fellner, C., Fitzpatrick, D., Klapach, A. S., Frantz, R. A., & Hillis, S. L. (2004) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200404000-00008 · Cited by 42

Authors: The Diabetes Control and Complications Trial Research Group.
Corresponding author: The Diabetes Control and Complications Trial Research Group.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 1995-04-15
Volume: 122
Issue: 8
Pages: 561-568
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-122-8-199504150-00001
OpenAlex: W4245107010
Cited by: 602
References: 0
Citations by year: 2026: 7 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 22 · 2021: 18 · 2020: 17 · 2019: 10 · 2018: 24 · 2017: 22 · 2016: 24 · 2015: 19 · 2014: 25 · 2013: 23 · 2012: 24
FWCI: 8.76
Type: journal article
Language: en
Open access: closed
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Keywords: intensive diabetes therapy, diabetic neuropathy, diabetic polyneuropathy, type 1 diabetes, glycemic control, insulin pump therapy, multiple daily insulin injections, nerve conduction velocity, autonomic dysfunction, neuropathy prevention, Diabetes Control and Complications Trial
MeSH terms: Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Follow-Up Studies, Humans, Infusion Pumps, Insulin Infusion Systems, Neural Conduction, Patient Compliance, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks